← Open Payments lookup

JAMES BAUGHMAN: Open Payments

NPI 1932861580 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,777 in 154 payments from 12 companies in 2025. Trend: 2023 $3,231 · 2024 $925 · 2025 $3,777

Food & beverage: $3,705Education: $71
CompanyPaymentsAmount
Alkermes, Inc.23$597
Teva Pharmaceuticals USA, Inc.18$567
Vanda Pharmaceuticals Inc.28$559
Otsuka America Pharmaceutical, Inc.15$364
Neurocrine BioSciences, Inc.14$341
Janssen Pharmaceuticals, Inc9$340
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$323
Lundbeck LLC18$201
E.R. Squibb & Sons, L.L.C.10$194
Axsome Therapeutics, Inc.5$183

Products named: FANAPT, REXULTI, UZEDY, INGREZZA, CAPLYTA, ARISTADA, LYBALVI, INVEGA SUSTENNA.

Industry payments across TX — which companies pay providers there.